Cardiovascular diseases, including ischaemic heart diseases and stroke, are the leading causes of death worldwide and in Malaysia.1,2 The world’s biggest killer is ischaemic heart disease, responsible for 16% of the world’s total deaths, amounting to 8.9 million deaths in 2019.1
4 in 10 Malaysian adults (8 million people) have raised total cholesterol level, and 1 in 3 Malaysians have uncontrolled cholesterol levels despite on medications.2
Low-density lipoprotein cholesterol (LDL-C) has been identified as a modifiable risk that is causally associated with atherosclerotic cardiovascular disease (ASCVD) risk.3 ASCVD events can be reduced by 22% with each 1 mmol/L reduction of LDL-C.4
Read more on the latest clinical evidence about lipid management below.
References
1.World Health Organization (WHO). The top 10 causes of death. Updated 9 December 2020. Accessed from https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
2.Institute for Public Health Malaysia 2020. National Health and Morbidity Survey (NHMS) 2019: Non-communicable diseases, healthcare demand and health literacy- Key findings.
3.Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111-88.
4. Grundy SM, et al. Guidelines for the management of high blood cholesterol. [Updated 2019 Nov 30]. In: Feingold KR, et al., editors. Endotext [Internet]. South Dartmouth (MA) 2000.